What factors drive the 7MM Angelman syndrome market? | Asian Business Review
Photo from Envato

What factors drive the 7MM Angelman syndrome market?

The rare neurogenetic disorder affects around 500,000 people worldwide.

Rising prevalence, greater awareness and diagnosis, and the introduction of new therapies are expected to drive growth in the Angelman syndrome market across the seven major markets (7MM), according to DelveInsight.

Long-term support is needed for people with the condition as they grow into adulthood, including vocational training, independent living support, and access to specialised healthcare, the report said.

Meanwhile, current research into experimental therapies, such as gene therapy and targeted drug treatments, offer potential breakthroughs in managing the condition.

Whilst no cure exists, therapies such as antiepileptic drugs for seizure control, behavioural interventions, augmentative communication methods, and physical and occupational therapies are commonly used to support patients.

Angelman syndrome, which affects around 500,000 people worldwide, is characterised by developmental delays, intellectual disabilities, severe speech impairments, and distinctive behavioural traits.

7MM = US, Germany, Spain, Italy, France, UK, and Japan.

Follow the link for more news on

Join Asian Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!